Nana Bie

2.4k total citations · 3 hit papers
31 papers, 2.0k citations indexed

About

Nana Bie is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Nana Bie has authored 31 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Biomedical Engineering and 8 papers in Immunology. Recurrent topics in Nana Bie's work include Nanoplatforms for cancer theranostics (10 papers), Extracellular vesicles in disease (6 papers) and Nanoparticle-Based Drug Delivery (6 papers). Nana Bie is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Extracellular vesicles in disease (6 papers) and Nanoparticle-Based Drug Delivery (6 papers). Nana Bie collaborates with scholars based in China, United States and United Kingdom. Nana Bie's co-authors include Lu Gan, Xiangliang Yang, Tuying Yong, Xiaoqiong Zhang, Zhaohan Wei, Fuying Li, Xuting Zhang, Abdul Hakeem, Jun Hu and Hongbo Zhang and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Nana Bie

30 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy

2019 679 citations Tuying Yong, Xiaoqiong Zhang et al. Nature Communications profile →
Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles

2021 271 citations Zhaohan Wei, Xiaoqiong Zhang et al. Nature Communications profile →
Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts

2022 200 citations Xin Li, Tuying Yong et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nana Bie China	17	1.0k	980	460	430	364	31	2.0k
Peixin Liu China	22	791 0.8×	541 0.6×	328 0.7×	352 0.8×	305 0.8×	57	2.1k
Jin Yan China	29	1.1k 1.0×	620 0.6×	444 1.0×	228 0.5×	281 0.8×	87	2.1k
Yan Fang China	24	1.1k 1.1×	424 0.4×	415 0.9×	350 0.8×	507 1.4×	102	2.3k
Liangjie Hong China	19	638 0.6×	944 1.0×	581 1.3×	255 0.6×	178 0.5×	28	2.1k
Xueping Xie China	29	1.5k 1.5×	729 0.7×	395 0.9×	222 0.5×	224 0.6×	43	2.8k
Xun Sun China	30	1.4k 1.4×	1.0k 1.1×	691 1.5×	543 1.3×	360 1.0×	60	2.9k
In‐Kyu Park South Korea	26	834 0.8×	1.1k 1.2×	732 1.6×	292 0.7×	184 0.5×	62	2.3k
Wangxiao He China	28	920 0.9×	570 0.6×	393 0.9×	238 0.6×	147 0.4×	72	1.9k
Feng Lv China	31	821 0.8×	1.1k 1.1×	545 1.2×	403 0.9×	239 0.7×	78	2.3k
Jinsheng Huang China	27	754 0.7×	848 0.9×	406 0.9×	395 0.9×	111 0.3×	67	2.0k

Countries citing papers authored by Nana Bie

Since Specialization

Citations

This map shows the geographic impact of Nana Bie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nana Bie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nana Bie more than expected).

Fields of papers citing papers by Nana Bie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nana Bie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nana Bie. The network helps show where Nana Bie may publish in the future.

Co-authorship network of co-authors of Nana Bie

This figure shows the co-authorship network connecting the top 25 collaborators of Nana Bie. A scholar is included among the top collaborators of Nana Bie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nana Bie. Nana Bie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Haojie, Tuying Yong, Xiaoqiong Zhang, et al.. (2025). Spatial Regulation of Cancer-Associated Fibroblasts and Tumor Cells via pH-Responsive Bispecific Antibody Delivery for Enhanced Chemo-Immunotherapy Synergy. ACS Nano. 19(12). 11756–11773. 4 indexed citations

Bie, Nana, Shiyu Li, Qingle Liang, et al.. (2025). Tumor-Repopulating Cell-Derived Microparticle-Based Therapeutics Amplify the Antitumor Effect through Synergistic Inhibition of Chemoresistance and Immune Evasion. Molecular Pharmaceutics. 22(2). 733–746.

Bie, Nana, Haojie Liu, Xin Li, et al.. (2025). Obesity Boosts the Tumor Delivery and Anticancer Effects of Liposomal Doxorubicin by an Apolipoprotein E-Mediated Mechanism. Molecular Pharmaceutics. 23(1). 196–208. 1 indexed citations

Bie, Nana, Wen Pan, Ya‐Ru Miao, et al.. (2024). A method for predicting drugs that can boost the efficacy of immune checkpoint blockade. Nature Immunology. 25(4). 659–670. 12 indexed citations

Zheng, Wenxia, Jianye Li, Jiaojiao Li, et al.. (2024). In-situ nanoplatform with synergistic neutrophil intervention and chemotherapy to prevent postoperative tumor recurrence and metastasis. Journal of Controlled Release. 375. 316–330. 2 indexed citations

Wei, Yi, Tuying Yong, Wenlong Jia, et al.. (2023). Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p. Advanced Science. 10(17). e2207080–e2207080. 19 indexed citations

Liu, Haojie, Tuying Yong, Zhaohan Wei, et al.. (2023). Hydrophobicity‐Adaptive Polymers Trigger Fission of Tumor‐Cell‐Derived Microparticles for Enhanced Anticancer Drug Delivery. Advanced Materials. 35(45). e2211980–e2211980. 10 indexed citations

Bie, Nana, Tuying Yong, Zhaohan Wei, et al.. (2023). Tumor-repopulating cell-derived microparticles elicit cascade amplification of chemotherapy-induced antitumor immunity to boost anti-PD-1 therapy. Signal Transduction and Targeted Therapy. 8(1). 31 indexed citations

Zhang, Xiaoqiong, Zhaohan Wei, Tuying Yong, et al.. (2023). Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8+ T cells to boost anti-PD-1 therapy. Nature Communications. 14(1). 5653–5653. 70 indexed citations

10.

Li, Xin, Tuying Yong, Zhaohan Wei, et al.. (2022). Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts. Nature Communications. 13(1). 2794–2794. 200 indexed citations breakdown →

11.

Feng, Xiaojuan, Nana Bie, Jingyao Li, et al.. (2022). Effect of in vitro simulated gastrointestinal digestion on the antioxidant activity, molecular weight, and microstructure of polysaccharides from Chinese yam. International Journal of Biological Macromolecules. 207. 873–882. 40 indexed citations

12.

Bie, Nana, Tuying Yong, Zhaohan Wei, Lu Gan, & Xiangliang Yang. (2022). Extracellular vesicles for improved tumor accumulation and penetration. Advanced Drug Delivery Reviews. 188. 114450–114450. 47 indexed citations

13.

Liang, Qingle, Nana Bie, Tuying Yong, et al.. (2021). Author Correction: The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency. Nature Biomedical Engineering. 5(5). 481–481. 2 indexed citations

14.

Zhan, Guiting, Qingbo Xu, Zelong Zhang, et al.. (2021). Biomimetic sonodynamic therapy-nanovaccine integration platform potentiates Anti-PD-1 therapy in hypoxic tumors. Nano Today. 38. 101195–101195. 104 indexed citations

15.

Wei, Zhaohan, Xiaoqiong Zhang, Tuying Yong, et al.. (2021). Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles. Nature Communications. 12(1). 440–440. 271 indexed citations breakdown →

16.

Yong, Tuying, Xiaoqiong Zhang, Nana Bie, et al.. (2019). Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nature Communications. 10(1). 3838–3838. 679 indexed citations breakdown →

17.

Liang, Qingle, Nana Bie, Tuying Yong, et al.. (2019). The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency. Nature Biomedical Engineering. 3(9). 729–740. 189 indexed citations

18.

Bie, Nana, Lirong Han, Meng Meng, et al.. (2019). Anti-tumor mechanism of eicosapentaenoic acid (EPA) on ovarian tumor model by improving the immunomodulatory activity in F344 rats. Journal of Functional Foods. 65. 103739–103739. 11 indexed citations

19.

Xu, Qingbo, Jiangshan Wan, Nana Bie, et al.. (2018). A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation. Theranostics. 8(19). 5362–5378. 53 indexed citations

20.

Li, Fuying, Hao Yang, Nana Bie, et al.. (2017). Zwitterionic Temperature/Redox-Sensitive Nanogels for Near-Infrared Light-Triggered Synergistic Thermo-Chemotherapy. ACS Applied Materials & Interfaces. 9(28). 23564–23573. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact